Cancer mortality in the USA has dropped by 33% since 1991 as a result of better treatments and earlier diagnoses. Winning the war on cancer.
Two new peer-reviewed studies about the incidence of HPV-related oropharyngeal cancer provides more evidence for the importance of the HPV vaccine. There are so few evidence-based methods to prevent cancer, it is shocking that so many people forgo the HPV vaccine for their children and for themselves.
I think one of the misunderstandings about HPV and the HPV vaccine is that it’s all about cervical cancer, a serious disease by itself. But many people overlook that possibly half of HPV-related cancers are not about cervical cancer, but numerous other cancers that are just as deadly.
In fact, HPV-associated cancers are increasing in men, but are dropping in women, because women had a head-start in getting the HPV vaccine.
We can all predict that the anti-vaccine crackpots will claim that HPV has nothing to do with cancer or a good organic, GMO-free, blueberry kale smoothie will prevent oropharyngeal cancer. However, for those of us who care about scientific evidence, please read on.Read More »HPV-related oropharyngeal cancer – more reasons for the HPV vaccine
You’ve probably seen their commercials spread over all of the major TV networks. Beautiful scenes. Well-kept hospitals which often to appear to be near empty. And an anecdote or two or three from presumably real patients who describe their experience at Cancer Treatment Centers of America (CTCA), a private, for-profit operator of cancer treatment hospitals and outpatient clinics which provide both conventional and alternative medical treatments. Included in their treatment plans are chiropractic and naturopathy, neither of which have any evidence whatsoever in providing any healthcare benefit to patients, let alone those suffering from cancer.
Reuters recently published an in-depth report on the validity of the claims that are made by CTCA in its advertising. Here are some of the ones specifically mentioned:
- For breast cancer, CTCA claims that its survival rate after 3.5 years post-diagnosis is about 42%, compared to the National Cancer Institute’s SEER (Surveillance Epidemiology and End Results) Program result (more or less a nationwide average) of about 29%. That’s a 13% improvement.
- For prostate cancer, CTCA claims that its 4 year survival rate is 20 points higher.
- For advanced colon cancer, CTCA claims that its 1.5 year survival rate is 11 points higher.Read More »Cancer Treatment Centers of America advertising